Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein

Preliminary Study on Type I Interferon as a Mucosal Adjuvant for Human Respiratory Syncytial Virus F Protein

<b>Background: </b>Human respiratory syncytial virus (HRSV) imposes a significant disease burden on infants and the elderly. Intranasal immunization using attenuated live vaccines and certain vector vaccines against HRSV has completed phase II clinical trials with good safety and efficac...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongqiao Hu, Li Zhang, Lei Cao, Jie Jiang, Yuqing Shi, Hong Guo, Yang Wang, Hai Li, Yan Zhang
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Vaccines
Subjects:
human respiratory syncytial virus
type I interferon
mucosal adjuvant
protective effects
Online Access:https://www.mdpi.com/2076-393X/12/11/1297
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/12/11/1297

Similar Items